Detalles de la búsqueda
1.
Early-Onset albuminuria and Associated Renal Pathology in Leucine-Rich Repeat Kinase 2 Knockout Rats.
Toxicol Pathol
; 51(1-2): 15-26, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078689
2.
Effects of LRRK2 Inhibitors in Nonhuman Primates.
Toxicol Pathol
; 51(5): 232-245, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37916535
3.
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase Activity.
J Pharmacol Exp Ther
; 377(1): 11-19, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509901
4.
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease.
J Med Chem
; 66(21): 14912-14927, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861679
5.
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.
J Med Chem
; 65(1): 838-856, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967623
6.
2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity.
Bioorg Med Chem Lett
; 21(11): 3399-403, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21524576
7.
Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation.
Toxicol Sci
; 82(1): 341-58, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15319485
8.
Differential cytotoxicity responses by dog and rat hepatocytes to phospholipogenic treatments.
J Toxicol
; 2013: 956404, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23577025
9.
Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies.
J Toxicol
; 2012: 308594, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22745636
Resultados
1 -
9
de 9
1
Próxima >
>>